WEED Inc. Acquires Hempirical Genetics, With Over 250 Proprietary Cannabis & Hemp Strains For $750K
WEED Inc. Acquires Hempirical Genetics, With Over 250 Proprietary Cannabis & Hemp Strains For $750K
WEED, Inc. (OTCQB:BUDZ) a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases, acquired 100% of Hempirical Genetics, LLC, for 2 million shares of common stock valued at $.25 per share and $250,000 in cash over 4 years. One million shares and $10,000 was paid on signing this agreement.
威德公司(場外交易代碼：BADZ)是一家總部位於美國的全球大麻和大麻生物研究公司，專注於開發和應用大麻衍生化合物，用於治療人類和動物疾病。收購半經驗遺傳公司100%的股份，用於200萬股每股價值0.25美元的普通股以及25萬美元的現金四年多了。在簽署這份協議時，支付了100萬股和1萬美元。
Glenn E. Martin, WEED, Inc.'s CEO stated, "Our teams in USA, Australia and Israel are excited that a pipeline of Original "Landrace" strains from the 1970s' can now be moved into clinical trials and product development for the global market. WEED now has over 15 "PURE" original, pristine, F-1 grade cannabis strains today, including, Panama Red, Acapulco Gold, Red Bud Colombian & Santa Marta Gold. Our newly acquired inventory includes over 30 CBD & CBG strains as WEED believes that multiple combinations of precise cannabinoid strains will create the entourage effect to achieve the medical outcome desired. Eventually, WEED plans to bring our unique desired strains to the Adult Use markets once the "Law of the Land" brings back the Freedoms lost 70+ years ago."
格林·E·馬丁我們在美國、澳大利亞和以色列的團隊很興奮，因為20世紀70年代的一批原始的長白氏菌株現在可以進入臨牀試驗和全球市場的產品開發。威德公司現在有15個以上。純淨“原始的，原始的，F-1今天的大麻品種等級，包括，巴拿馬紅，阿卡普爾科金色，哥倫比亞紅芽和聖瑪爾塔金色。我們新獲得的庫存包括30多種CBD和CBG菌株，因為雜草相信，精確的大麻素菌株的多種組合將產生環境效應，以實現預期的醫療結果。最終，威德計劃一旦《土地法》將70多年前失去的自由帶回市場，就會將我們獨特的所需品種帶到成人用品市場。
Jeffery Miller, the previous owner of Hempirical Genetics, will lead the charge in strain & product development as HEMP BioScience's new CEO. Martin continued, "I've known Jeff for a half a century. His horticulture skills and dedication the Cannabaceae plant cannot be duplicated. I'm extremely proud to have my old friend and his team, (whose strains WEED bought in the acquisition), which we believe will bring year-over-year success to the benefit of WEED's shareholders."
傑弗裏·米勒，以前是HEMPLICAL Genetics的所有者，將領導菌株和產品開發，作為大麻生物科學馬丁繼續説：“我認識傑夫有半個世紀了。他的園藝技能和對大麻植物的奉獻是不可複製的。我非常自豪有我的老朋友和他的團隊(他們的品系威德在收購中被收購)，我們相信他們將帶來年復一年的成功，讓威德的股東受益。”
Miller stated, "I've known Glenn Martin for 50+ years and honored to take the helm of HEMP BioSciences to buildout our genetic studies. My goal is to bring the strongest, highest quality THC and hemp products to market at affordable prices. "Double the quality, half the price" should be the mantra for the cannabis industry, while creating diversity & equality to the cannabis sector. Our Veterans have been highly overlooked, and I look to develop vet programs at low or no cost, which I know is a priority of Glenn and mine."
米勒説：“我認識格倫·馬丁50多年了，我很榮幸能執掌大麻生物科學公司，為我們的基因研究奠定基礎。我的目標是以合理的價格將最強大、最高質量的THC和大麻產品推向市場。”質量加倍，價格減半“應該是大麻行業的口號，同時為大麻行業創造多樣性和平等。我們的退伍軍人一直被高度忽視，我希望以低成本或免費的方式發展獸醫項目，我知道這是格倫和我的優先事項。”
Photo by CRYSTALWEED cannabis on Unsplash
結晶器大麻在Unspash上的照片